Related Experiment Videos
Treatment of feline leukemia virus (FeLV) infection
1I. Medizinische Tierklinik, Ludwig-Maximilians-Universität München, Munich, Germany. k.hartmann@lrz.uni-muenchen.de
Insights
Feline leukemia virus (FeLV) infection causes many cat deaths. Early studies suggested an immunomodulator, PIND-ORF (Baypamun), could cure FeLV, leading to widespread use in Europe.
Area of Science:
- Veterinary Medicine
- Immunology
- Virology
Background:
- Feline leukemia virus (FeLV) is a primary cause of disease-related mortality in pet cats.
- Previous treatments for FeLV have failed to achieve healing or complete virus elimination.
- Initial reports suggested an immunomodulating compound, PIND-ORF (Baypamun), could effectively cure FeLV-infected cats.
Purpose of the Study:
- To evaluate the therapeutic efficacy of Baypamun and other compounds in naturally FeLV-infected cats.
- To determine if the promising results of earlier studies could be replicated under controlled conditions.
- To assess the effectiveness of an immunomodulator in treating FeLV viremia.
Main Methods:
- Conducted four placebo-controlled, double-blind trials.
- Utilized naturally FeLV-infected cats as subjects.
- Investigated the efficacy of Baypamun (PIND-ORF) and other compounds.
Main Results:
- The initial studies reported high cure rates (80-100%) for FeLV viremia using PIND-ORF.
- Baypamun became a commonly used treatment for FeLV in Germany and Europe following these reports.
- The current study aimed to validate these findings through rigorous, controlled trials.
Conclusions:
- Despite widespread use based on early findings, the efficacy of Baypamun in treating FeLV requires confirmation through controlled studies.
- Further research is needed to establish reliable treatments for FeLV infection in cats.
- The effectiveness of immunomodulators like PIND-ORF in FeLV treatment remains under investigation.
Abstract:
FeLV infection is still considered to account for most disease-related deaths in pet cats. Different treatment attempts with various drugs were performed in the past but none resulted in healing or complete virus elimination. Therefore, it caused a sensation when Horber and Mayr [Horber, D., Mayr, B., 1991. Prax. 19, 311-314; Horber, D., Schnabl, W., Mayr, B., 1992. Tierarztl. Umschau 47, 556-560; Mayr, B., Horber, D., 1992. Kleintierprax. 37, 515-518] published that they were able to cure 80 to 100% FeLV-infected cats from viremia by using an immunomodulating compound. Articles in cat breeder and cat owner journals appeared assuming that obviously there is a rescue for FeLV-infected cats suffering from this deadly infection. The immunomodulator [Buttner, M., 1993. Comp. Immun. Microbiol. Infect. Dis. 18, 1-10] used in those studies was the so-called 'paramunity inducer' PIND-ORF (Baypamun, Bayer, Leverkusen, Germany) consisting of inactivated parapox ovis virus. Since that time, Baypamun is the most commonly used drug for treatment of FeLV infection in Germany and other European countries. Four placebo-controlled double-blind trials were performed to determine the therapeutic efficacy of Baypamun and other compounds in naturally FeLV-infected cats under controlled conditions.